Grameenphone Partners with Mobileum to Launch AI-Driven Risk Management Transformation
Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, is pleased to announce that Grameenphone, Bangladesh’s largest telecommunications service provider with more than 85 million subscribers, has selected Mobileum’s next-generation revenue assurance and fraud management (RAFM) solution, built on its flagship Active Intelligence Platform (AIP), to conduct its risk management transformation. This strategic partnership will empower Grameenphone to identify and prevent revenue leakage, strengthen fraud detection, and deliver customers a more secure and efficient service.
“In today's dynamic business landscape, ensuring customer experience and combating fraud are critical business imperatives. By implementing this cutting-edge AI-powered solution, we are taking a proactive approach to safeguarding our future and ensuring our customers receive the highest quality service with less concerns about fraud and security threats,” said Yasir Azman, CEO at Grameenphone.
As part of this partnership, Grameenphone will upgrade technology, train staff, and collaborate with Mobileum for continuous improvement to adapt to evolving threats and market conditions. Initially, the focus will be on implementing advanced AI and machine learning tools to enhance existing systems, while providing comprehensive training for Grameenphone’s staff to effectively utilize these technologies.
“We are proud to partner with Grameenphone on this transformative journey and we anticipate a strong positive impact on all stakeholders. Continuous improvement is a fundamental aspect of this engagement, and it will ensure that Grameenphone remains ahead of potential risks, maintaining secure and efficient operations. By adopting this innovative solution, Grameenphone can protect its customers from potential fraud, secure revenue streams, optimize operations, and comply with regulatory requirements,” stated Mike Salfity, CEO at Mobileum.
“At Grameenphone, we are committed to continuous innovation and leveraging cutting-edge AI-driven technology to enhance our services. Mobileum's Active Intelligence Platform aligns perfectly with our vision of AI-first Telco. It will equip us with advanced analytics to identify and prevent revenue leakage, strengthen our fraud detection capabilities, and ultimately ensure we deliver the best possible value to our customers,” stated Niranjan Srinivasan, Chief Information Officer at Grameenphone.
“We are excited to implement this innovative RAFM system. It is designed to provide a better customer experience, protect against fraudulent activity through advanced AI technology, and reinforces our commitment to continuous innovation in our services,” said Md. Arif Uddin, Chief Risk Officer at Grameenphone.
Mobileum AIP is a comprehensive platform that utilizes machine learning algorithms to analyze large and high frequency data streams in real time. By deploying this solution, Grameenphone will make considerable progress in terms of proactive assurance, enhanced fraud detection and deeper customer intelligence.
“We're deploying Mobileum's AI-powered solution to elevate customer experience. This next-generation platform will proactively safeguard Grameenphone's customers from fraud, ensuring a secure network environment. Additionally, it will provide us with deeper insights into usage patterns. This knowledge empowers us to optimize network performance and ultimately deliver the best possible value to our valued customers,” stated Tanveer M. Haque, Head of Data Analytics at Grameenphone.
“Grameenphone’s RAFM Transformation Project is a pivotal initiative highlighting Mobileum’s commitment to innovation and leadership in revenue assurance and fraud management. This initiative provides Grameenphone with robust tools to secure revenue, optimize efficiency, and ensure compliance. Advanced technology will enable Grameenphone to proactively identify and mitigate risk, ensuring financial stability in an increasingly complex market,” stated Raja Hussain, Chief Revenue Officer at Mobileum.
To learn more about how Mobileum’s risk management portfolio is helping service providers across the world maximize revenues and strengthen fraud protection, please click here.
About Grameenphone
Grameenphone, part of the Telenor Group, is a leading telecommunications service provider in Bangladesh with 85.3 million subscribers. Since its inception in 1997, Grameenphone has built the largest cellular network in the country, covering over 99 percent of the country's population. With its brand promise to enable customers to "Go beyond," Grameenphone seeks to help customers get the full benefit of mobile data and voice services and provide Internet For All. Grameenphone is listed on the Dhaka Stock Exchange. www.grameenphone.com, www.facebook.com/grameenphone.
About Mobileum Inc.
Mobileum is a leading provider of Telecom analytics solutions for roaming, core network, security, risk management, domestic and international connectivity testing, and customer intelligence. More than 1,000 customers rely on its Active Intelligence platform, which provides advanced analytics solutions, allowing customers to connect deep network and operational intelligence with real-time actions that increase revenue, improve customer experience, and reduce costs. Headquartered in Silicon Valley, Mobileum has global offices in Australia, Germany, Greece, India, Japan, Portugal, Singapore, UK, and United Arab Emirates.
Learn more at https://www.mobileum.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240806817462/en/
Contacts
QUEXOR GROUP INC.
Barbara Henris | bhenris@quexor.com | Mob.: +1 (703) 470-9446
Media and Corporate Communications – Mobileum
Sandra Almeida | sandra.almeida@mobileum.com | Mob. +351 939650229
Corporate Communications Manager – Grameenphone
Tazriba Khurshid | tazriba.khurshid@grameenphone.com | Mob: +88 01 711092233
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 13:00:00 CET | Press Release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom